{"pmid":32380844,"title":"Canadian Association of Thoracic Radiology/Canadian Association of Radiologists Consensus Statement Regarding Chest Imaging in Suspected and Confirmed COVID-19.","text":["Canadian Association of Thoracic Radiology/Canadian Association of Radiologists Consensus Statement Regarding Chest Imaging in Suspected and Confirmed COVID-19.","On March 11, 2020, the World Health Organization declared infection related to a novel coronavirus (SARS-CoV-2) a pandemic. The role and impact of imaging predates this declaration and continues to change rapidly. This article is a consensus statement provided by the Canadian Society of Thoracic Radiology and the Canadian Association of Radiologists outlining the role of imaging in COVID-19 patients. The objectives are to answer key questions related to COVID-19 imaging of the chest and provide guidance for radiologists who are interpreting such studies during this pandemic. The role of chest radiography (CXR), computed tomography (CT), and lung ultrasound is discussed. This document attempts to answer key questions for the imager when dealing with this crisis, such as \"When is CXR appropriate in patients with suspected or confirmed COVID-19 infection?\" or \"How should a radiologist deal with incidental findings of COVID-19 on CT of the chest done for other indications?\" This article also provides recommended reporting structure for CXR and CT, breaking diagnostic possibilities for both CXR and CT into 3 categories: typical, nonspecific, and negative based on imaging findings with representative images provided. Proposed reporting language is also outlined based on this structure. As our understanding of this pandemic evolves, our appreciation for how imaging fits into the workup of patients during this unprecedented time evolves as well. Although this consensus statement was written using the most recent literature, it is important to maintain an open mind as new information continues to surface.","Can Assoc Radiol J","Dennie, Carole","Hague, Cameron","Lim, Robert S","Manos, Daria","Memauri, Brett F","Nguyen, Elsie T","Taylor, Jana","32380844"],"abstract":["On March 11, 2020, the World Health Organization declared infection related to a novel coronavirus (SARS-CoV-2) a pandemic. The role and impact of imaging predates this declaration and continues to change rapidly. This article is a consensus statement provided by the Canadian Society of Thoracic Radiology and the Canadian Association of Radiologists outlining the role of imaging in COVID-19 patients. The objectives are to answer key questions related to COVID-19 imaging of the chest and provide guidance for radiologists who are interpreting such studies during this pandemic. The role of chest radiography (CXR), computed tomography (CT), and lung ultrasound is discussed. This document attempts to answer key questions for the imager when dealing with this crisis, such as \"When is CXR appropriate in patients with suspected or confirmed COVID-19 infection?\" or \"How should a radiologist deal with incidental findings of COVID-19 on CT of the chest done for other indications?\" This article also provides recommended reporting structure for CXR and CT, breaking diagnostic possibilities for both CXR and CT into 3 categories: typical, nonspecific, and negative based on imaging findings with representative images provided. Proposed reporting language is also outlined based on this structure. As our understanding of this pandemic evolves, our appreciation for how imaging fits into the workup of patients during this unprecedented time evolves as well. Although this consensus statement was written using the most recent literature, it is important to maintain an open mind as new information continues to surface."],"journal":"Can Assoc Radiol J","authors":["Dennie, Carole","Hague, Cameron","Lim, Robert S","Manos, Daria","Memauri, Brett F","Nguyen, Elsie T","Taylor, Jana"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32380844","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1177/0846537120924606","keywords":["covid-19","chest computed tomography","chest radiograph","infection","lung ultrasound","pneumonia"],"topics":["Diagnosis"],"weight":1,"_version_":1666419683211870208,"score":9.490897,"similar":[{"pmid":32275978,"pmcid":"PMC7138384","title":"The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society.","text":["The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society.","With more than 900,000 confirmed cases worldwide and nearly 50,000 deaths during the first three months of 2020, the COVID-19 pandemic has emerged as an unprecedented healthcare crisis. The spread of COVID-19 has been heterogeneous, resulting in some regions having sporadic transmission and relatively few hospitalized patients with COVID-19 and others having community transmission that has led to overwhelming numbers of severe cases. For these regions, healthcare delivery has been disrupted and compromised by critical resource constraints in diagnostic testing, hospital beds, ventilators, and healthcare workers who have fallen ill to the virus exacerbated by shortages of personal protective equipment. While mild cases mimic common upper respiratory viral infections, respiratory dysfunction becomes the principal source of morbidity and mortality as the disease advances. Thoracic imaging with chest radiography (CXR) and computed tomography (CT) are key tools for pulmonary disease diagnosis and management, but their role in the management of COVID-19 has not been considered within the multivariable context of the severity of respiratory disease, pre-test probability, risk factors for disease progression, and critical resource constraints. To address this deficit, a multidisciplinary panel comprised principally of radiologists and pulmonologists from 10 countries with experience managing COVID-19 patients across a spectrum of healthcare environments evaluated the utility of imaging within three scenarios representing varying risk factors, community conditions, and resource constraints. Fourteen key questions, corresponding to 11 decision points within the three scenarios and three additional clinical situations, were rated by the panel based upon the anticipated value of the information that thoracic imaging would be expected to provide. The results were aggregated, resulting in five main and three additional recommendations intended to guide medical practitioners in the use of CXR and CT in the management of COVID-19.","Chest","Rubin, Geoffrey D","Ryerson, Christopher J","Haramati, Linda B","Sverzellati, Nicola","Kanne, Jeffrey P","Raoof, Suhail","Schluger, Neil W","Volpi, Annalisa","Yim, Jae-Joon","Martin, Ian B K","Anderson, Deverick J","Kong, Christina","Altes, Talissa","Bush, Andrew","Desai, Sujal R","Goldin, Jonathan","Goo, Jin Mo","Humbert, Marc","Inoue, Yoshikazu","Kauczor, Hans-Ulrich","Luo, Fengming","Mazzone, Peter J","Prokop, Mathias","Remy-Jardin, Martine","Richeldi, Luca","Schaefer-Prokop, Cornelia M","Tomiyama, Noriyuki","Wells, Athol U","Leung, Ann N","32275978"],"abstract":["With more than 900,000 confirmed cases worldwide and nearly 50,000 deaths during the first three months of 2020, the COVID-19 pandemic has emerged as an unprecedented healthcare crisis. The spread of COVID-19 has been heterogeneous, resulting in some regions having sporadic transmission and relatively few hospitalized patients with COVID-19 and others having community transmission that has led to overwhelming numbers of severe cases. For these regions, healthcare delivery has been disrupted and compromised by critical resource constraints in diagnostic testing, hospital beds, ventilators, and healthcare workers who have fallen ill to the virus exacerbated by shortages of personal protective equipment. While mild cases mimic common upper respiratory viral infections, respiratory dysfunction becomes the principal source of morbidity and mortality as the disease advances. Thoracic imaging with chest radiography (CXR) and computed tomography (CT) are key tools for pulmonary disease diagnosis and management, but their role in the management of COVID-19 has not been considered within the multivariable context of the severity of respiratory disease, pre-test probability, risk factors for disease progression, and critical resource constraints. To address this deficit, a multidisciplinary panel comprised principally of radiologists and pulmonologists from 10 countries with experience managing COVID-19 patients across a spectrum of healthcare environments evaluated the utility of imaging within three scenarios representing varying risk factors, community conditions, and resource constraints. Fourteen key questions, corresponding to 11 decision points within the three scenarios and three additional clinical situations, were rated by the panel based upon the anticipated value of the information that thoracic imaging would be expected to provide. The results were aggregated, resulting in five main and three additional recommendations intended to guide medical practitioners in the use of CXR and CT in the management of COVID-19."],"journal":"Chest","authors":["Rubin, Geoffrey D","Ryerson, Christopher J","Haramati, Linda B","Sverzellati, Nicola","Kanne, Jeffrey P","Raoof, Suhail","Schluger, Neil W","Volpi, Annalisa","Yim, Jae-Joon","Martin, Ian B K","Anderson, Deverick J","Kong, Christina","Altes, Talissa","Bush, Andrew","Desai, Sujal R","Goldin, Jonathan","Goo, Jin Mo","Humbert, Marc","Inoue, Yoshikazu","Kauczor, Hans-Ulrich","Luo, Fengming","Mazzone, Peter J","Prokop, Mathias","Remy-Jardin, Martine","Richeldi, Luca","Schaefer-Prokop, Cornelia M","Tomiyama, Noriyuki","Wells, Athol U","Leung, Ann N"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32275978","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.chest.2020.04.003","locations":["Thoracic"],"topics":["Diagnosis"],"weight":1,"_version_":1666138491718729728,"score":384.23676},{"pmid":32255413,"title":"The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society.","text":["The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society.","With more than 900,000 confirmed cases worldwide and nearly 50,000 deaths during the first three months of 2020, the COVID-19 pandemic has emerged as an unprecedented healthcare crisis. The spread of COVID-19 has been heterogeneous, resulting in some regions having sporadic transmission and relatively few hospitalized patients with COVID-19 and others having community transmission that has led to overwhelming numbers of severe cases. For these regions, healthcare delivery has been disrupted and compromised by critical resource constraints in diagnostic testing, hospital beds, ventilators, and healthcare workers who have fallen ill to the virus exacerbated by shortages of personal protective equipment. While mild cases mimic common upper respiratory viral infections, respiratory dysfunction becomes the principal source of morbidity and mortality as the disease advances. Thoracic imaging with chest radiography (CXR) and computed tomography (CT) are key tools for pulmonary disease diagnosis and management, but their role in the management of COVID-19 has not been considered within the multivariable context of the severity of respiratory disease, pre-test probability, risk factors for disease progression, and critical resource constraints. To address this deficit, a multidisciplinary panel comprised principally of radiologists and pulmonologists from 10 countries with experience managing COVID-19 patients across a spectrum of healthcare environments evaluated the utility of imaging within three scenarios representing varying risk factors, community conditions, and resource constraints. Fourteen key questions, corresponding to 11 decision points within the three scenarios and three additional clinical situations, were rated by the panel based upon the anticipated value of the information that thoracic imaging would be expected to provide. The results were aggregated, resulting in five main and three additional recommendations intended to guide medical practitioners in the use of CXR and CT in the management of COVID-19.","Radiology","Rubin, Geoffrey D","Ryerson, Christopher J","Haramati, Linda B","Sverzellati, Nicola","Kanne, Jeffrey P","Raoof, Suhail","Schluger, Neil W","Volpi, Annalisa","Yim, Jae-Joon","Martin, Ian B K","Anderson, Deverick J","Kong, Christina","Altes, Talissa","Bush, Andrew","Desai, Sujal R","Goldin, Jonathan","Goo, Jin Mo","Humbert, Marc","Inoue, Yoshikazu","Kauczor, Hans-Ulrich","Luo, Fengming","Mazzone, Peter J","Prokop, Mathias","Remy-Jardin, Martine","Richeldi, Luca","Schaefer-Prokop, Cornelia M","Tomiyama, Noriyuki","Wells, Athol U","Leung, Ann N","32255413"],"abstract":["With more than 900,000 confirmed cases worldwide and nearly 50,000 deaths during the first three months of 2020, the COVID-19 pandemic has emerged as an unprecedented healthcare crisis. The spread of COVID-19 has been heterogeneous, resulting in some regions having sporadic transmission and relatively few hospitalized patients with COVID-19 and others having community transmission that has led to overwhelming numbers of severe cases. For these regions, healthcare delivery has been disrupted and compromised by critical resource constraints in diagnostic testing, hospital beds, ventilators, and healthcare workers who have fallen ill to the virus exacerbated by shortages of personal protective equipment. While mild cases mimic common upper respiratory viral infections, respiratory dysfunction becomes the principal source of morbidity and mortality as the disease advances. Thoracic imaging with chest radiography (CXR) and computed tomography (CT) are key tools for pulmonary disease diagnosis and management, but their role in the management of COVID-19 has not been considered within the multivariable context of the severity of respiratory disease, pre-test probability, risk factors for disease progression, and critical resource constraints. To address this deficit, a multidisciplinary panel comprised principally of radiologists and pulmonologists from 10 countries with experience managing COVID-19 patients across a spectrum of healthcare environments evaluated the utility of imaging within three scenarios representing varying risk factors, community conditions, and resource constraints. Fourteen key questions, corresponding to 11 decision points within the three scenarios and three additional clinical situations, were rated by the panel based upon the anticipated value of the information that thoracic imaging would be expected to provide. The results were aggregated, resulting in five main and three additional recommendations intended to guide medical practitioners in the use of CXR and CT in the management of COVID-19."],"journal":"Radiology","authors":["Rubin, Geoffrey D","Ryerson, Christopher J","Haramati, Linda B","Sverzellati, Nicola","Kanne, Jeffrey P","Raoof, Suhail","Schluger, Neil W","Volpi, Annalisa","Yim, Jae-Joon","Martin, Ian B K","Anderson, Deverick J","Kong, Christina","Altes, Talissa","Bush, Andrew","Desai, Sujal R","Goldin, Jonathan","Goo, Jin Mo","Humbert, Marc","Inoue, Yoshikazu","Kauczor, Hans-Ulrich","Luo, Fengming","Mazzone, Peter J","Prokop, Mathias","Remy-Jardin, Martine","Richeldi, Luca","Schaefer-Prokop, Cornelia M","Tomiyama, Noriyuki","Wells, Athol U","Leung, Ann N"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32255413","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1148/radiol.2020201365","locations":["Thoracic"],"topics":["Diagnosis"],"weight":1,"_version_":1666138493156327424,"score":384.23676},{"pmid":32468845,"title":"Emergency Radiology During the COVID-19 Pandemic: The Canadian Association of Radiologists Recommendations for Practice.","text":["Emergency Radiology During the COVID-19 Pandemic: The Canadian Association of Radiologists Recommendations for Practice.","Coronavirus Disease 2019 (COVID-19) is the disease caused by the novel coronavirus officially named the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), declared as a pandemic by the World Health Organization on March 11, 2020. The COVID-19 pandemic presents an unprecedented challenge to emergency radiology practice. The continuity of an effective emergency imaging service for both COVID-19 and non-COVID-19 patients is essential, while adhering to best infection control practices. Under the direction of the Board of the Canadian Association of Radiologists, this general guidance document has been synthesized by collaborative consensus of a group of emergency radiologists. These recommendations aim to assist radiologists involved in emergency diagnostic imaging to help mitigate the spread of COVID-19 and continue to add value to patient care in the emergency setting.","Can Assoc Radiol J","Redmond, Ciaran E","Nicolaou, Savvas","Berger, Ferco H","Sheikh, Adnan M","Patlas, Michael N","32468845"],"abstract":["Coronavirus Disease 2019 (COVID-19) is the disease caused by the novel coronavirus officially named the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), declared as a pandemic by the World Health Organization on March 11, 2020. The COVID-19 pandemic presents an unprecedented challenge to emergency radiology practice. The continuity of an effective emergency imaging service for both COVID-19 and non-COVID-19 patients is essential, while adhering to best infection control practices. Under the direction of the Board of the Canadian Association of Radiologists, this general guidance document has been synthesized by collaborative consensus of a group of emergency radiologists. These recommendations aim to assist radiologists involved in emergency diagnostic imaging to help mitigate the spread of COVID-19 and continue to add value to patient care in the emergency setting."],"journal":"Can Assoc Radiol J","authors":["Redmond, Ciaran E","Nicolaou, Savvas","Berger, Ferco H","Sheikh, Adnan M","Patlas, Michael N"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32468845","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1177/0846537120930344","keywords":["covid-19","emergency radiology"],"topics":["Prevention"],"weight":1,"_version_":1668167109915443201,"score":360.92102},{"pmid":32289051,"pmcid":"PMC7129441","title":"COVID-19 pneumonia manifestations at the admission on chest ultrasound, radiographs, and CT: single-center study and comprehensive radiologic literature review.","text":["COVID-19 pneumonia manifestations at the admission on chest ultrasound, radiographs, and CT: single-center study and comprehensive radiologic literature review.","Purpose: To investigate the imaging features of emerging COVID-19 pneumonia on chest ultrasound (US), radiographs (CXR) and computed tomography (CT) examinations performed at admission and to provide a comprehensive radiological literature review on ongoing radiological data from recent publications. Materials and methods: In this retrospective single-center study, we enrolled consecutive patients from February 15, 2020, to March 15, 2020, with laboratory-confirmed SARS-CoV-2 hospitalized in Valduce Hospital (Como, Italy). Multi-modality imaging findings were evaluated and compared. Literature research was conducted through a methodical search on Pubmed and Embase databases. Results: Fifty-eight patients (36 men, 22 women; age range, 18-98 years) were included in the study. Among these, chest US, CXR, and CT were performed respectively in twenty-two, thirty-two and forty-two patients. Lung US findings were consistent with diffuse B lines (100%) and subpleural consolidations (27.3%). CXR showed prevalent manifestations of consolidations (46.9%) and hazy increased opacities (37.5%). Typical CT features included bilateral and multilobar ground-glass opacities (GGO) with (59.5%) and without (35.7%) consolidations having a predominantly peripheral distribution (64.3%). Other imaging features included crazy paving pattern (57.1%), fibrous stripes (50%), subpleural lines (35.7%), architectural distortion (28.6%), air bronchogram sign (26.2%), vascular thickening (23.8%) and nodules (2.4%). Also, enlarged lymph nodes (14.3 %) and pleural effusion (7.1%) were observed. The literature review identified twenty-six original studies supporting our imaging chest findings. Conclusion: The spectrum of chest imaging manifestations of COVID-19 pneumonia upon admission includes B-lines and consolidations on US, consolidations and hazy increased opacities on CXR, and multifocal GGO with consolidations on CT.","Eur J Radiol Open","Lomoro, Pascal","Verde, Francesco","Zerboni, Filippo","Simonetti, Igino","Borghi, Claudia","Fachinetti, Camilla","Natalizi, Anna","Martegani, Alberto","32289051"],"abstract":["Purpose: To investigate the imaging features of emerging COVID-19 pneumonia on chest ultrasound (US), radiographs (CXR) and computed tomography (CT) examinations performed at admission and to provide a comprehensive radiological literature review on ongoing radiological data from recent publications. Materials and methods: In this retrospective single-center study, we enrolled consecutive patients from February 15, 2020, to March 15, 2020, with laboratory-confirmed SARS-CoV-2 hospitalized in Valduce Hospital (Como, Italy). Multi-modality imaging findings were evaluated and compared. Literature research was conducted through a methodical search on Pubmed and Embase databases. Results: Fifty-eight patients (36 men, 22 women; age range, 18-98 years) were included in the study. Among these, chest US, CXR, and CT were performed respectively in twenty-two, thirty-two and forty-two patients. Lung US findings were consistent with diffuse B lines (100%) and subpleural consolidations (27.3%). CXR showed prevalent manifestations of consolidations (46.9%) and hazy increased opacities (37.5%). Typical CT features included bilateral and multilobar ground-glass opacities (GGO) with (59.5%) and without (35.7%) consolidations having a predominantly peripheral distribution (64.3%). Other imaging features included crazy paving pattern (57.1%), fibrous stripes (50%), subpleural lines (35.7%), architectural distortion (28.6%), air bronchogram sign (26.2%), vascular thickening (23.8%) and nodules (2.4%). Also, enlarged lymph nodes (14.3 %) and pleural effusion (7.1%) were observed. The literature review identified twenty-six original studies supporting our imaging chest findings. Conclusion: The spectrum of chest imaging manifestations of COVID-19 pneumonia upon admission includes B-lines and consolidations on US, consolidations and hazy increased opacities on CXR, and multifocal GGO with consolidations on CT."],"journal":"Eur J Radiol Open","authors":["Lomoro, Pascal","Verde, Francesco","Zerboni, Filippo","Simonetti, Igino","Borghi, Claudia","Fachinetti, Camilla","Natalizi, Anna","Martegani, Alberto"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32289051","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.ejro.2020.100231","keywords":["covid-19","computed tomography (ct)","sars-cov-2","coronavirus disease","pneumonia","radiographic chest examination (cxr)","ultrasound (us)"],"locations":["US","Italy","US","US"],"countries":["United States","Italy"],"countries_codes":["USA|United States","ITA|Italy"],"topics":["Diagnosis"],"weight":1,"_version_":1666138491373748225,"score":340.56458},{"pmid":32302927,"pmcid":"PMC7141645","title":"Portable chest X-ray in coronavirus disease-19 (COVID-19): A pictorial review.","text":["Portable chest X-ray in coronavirus disease-19 (COVID-19): A pictorial review.","As the global pandemic of coronavirus disease-19 (COVID-19) progresses, many physicians in a wide variety of specialties continue to play pivotal roles in diagnosis and management. In radiology, much of the literature to date has focused on chest CT manifestations of COVID-19 (Zhou et al. [1]; Chung et al. [2]). However, due to infection control issues related to patient transport to CT suites, the inefficiencies introduced in CT room decontamination, and lack of CT availability in parts of the world, portable chest radiography (CXR) will likely be the most commonly utilized modality for identification and follow up of lung abnormalities. In fact, the American College of Radiology (ACR) notes that CT decontamination required after scanning COVID-19 patients may disrupt radiological service availability and suggests that portable chest radiography may be considered to minimize the risk of cross-infection (American College of Radiology [3]). Furthermore, in cases of high clinical suspicion for COVID-19, a positive CXR may obviate the need for CT. Additionally, CXR utilization for early disease detection may also play a vital role in areas around the world with limited access to reliable real-time reverse transcription polymerase chain reaction (RT-PCR) COVID testing. The purpose of this pictorial review article is to describe the most common manifestations and patterns of lung abnormality on CXR in COVID-19 in order to equip the medical community in its efforts to combat this pandemic.","Clin Imaging","Jacobi, Adam","Chung, Michael","Bernheim, Adam","Eber, Corey","32302927"],"abstract":["As the global pandemic of coronavirus disease-19 (COVID-19) progresses, many physicians in a wide variety of specialties continue to play pivotal roles in diagnosis and management. In radiology, much of the literature to date has focused on chest CT manifestations of COVID-19 (Zhou et al. [1]; Chung et al. [2]). However, due to infection control issues related to patient transport to CT suites, the inefficiencies introduced in CT room decontamination, and lack of CT availability in parts of the world, portable chest radiography (CXR) will likely be the most commonly utilized modality for identification and follow up of lung abnormalities. In fact, the American College of Radiology (ACR) notes that CT decontamination required after scanning COVID-19 patients may disrupt radiological service availability and suggests that portable chest radiography may be considered to minimize the risk of cross-infection (American College of Radiology [3]). Furthermore, in cases of high clinical suspicion for COVID-19, a positive CXR may obviate the need for CT. Additionally, CXR utilization for early disease detection may also play a vital role in areas around the world with limited access to reliable real-time reverse transcription polymerase chain reaction (RT-PCR) COVID testing. The purpose of this pictorial review article is to describe the most common manifestations and patterns of lung abnormality on CXR in COVID-19 in order to equip the medical community in its efforts to combat this pandemic."],"journal":"Clin Imaging","authors":["Jacobi, Adam","Chung, Michael","Bernheim, Adam","Eber, Corey"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32302927","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.clinimag.2020.04.001","keywords":["covid-19","chest ct","chest x-ray","coronavirus"],"topics":["Diagnosis"],"weight":1,"_version_":1666138494845583360,"score":314.77536}]}